surprisingly well-tolerated clinical molecule

Ph. III candidate in SCLC (4 mg IV QW)

from aerospace compound phenotypic screen

J. Med. Chem., May 27, 2021

EpicentRx Inc., La Jolla, CA

RRx-001

The EpiCentRx Myc and CD47 downregulating molecule with a range of proposed mechanisms, RRx-001, is a Ph. III clinical candidate with an eyebrow-raising chemical structure that originated from an even…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: